Increased nuchal translucency (NT), morphologically known as nuchal edema, is an ultrasound marker for aneuploidy. Turner syndrome presents with massive NT, called cystic hygroma. Conflicting data exist as to whether cystic hygroma and increased NT are different entities. Both are associated with jugular lymphatic distension. The authors investigated jugular lymphatics of trisomy 21, Turner syndrome, and normal karyotype fetuses. Fetuses were investigated using immunohistochemistry for blood vascular, lymphatic, and smooth muscle cell markers. Trisomy 21 fetuses showed nuchal cavities within the mesenchymal edema negative for endothelial markers. These were extremely large in Turner fetuses, showing similar characteristics. The skin showed numerous dilated lymphatics in the case of trisomy 21 and scanty small lymphatics in Turner fetuses. A jugular lymphatic sac was present in control and trisomy 21 fetuses and was enlarged in trisomy 21 cases. In Turner fetuses, no jugular lymphatic sac was observed. Nuchal edema in trisomy 21 and Turner syndrome appears to be a similar entity caused by different lymphatic abnormalities.
Nicolaides KH , Brizot ML, Snijders RJM.Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy . Br J Obstet Gynaecol. 1994;101:782-786.
2.
Haak MC, Bartelings MM, Jackson DG, Webb S., Van Vugt JMG, Gittenberger-de Groot ACIncreased nuchal translucency is associated with jugular lymphatic distension . Hum Reprod. 2002;17:1086-1092.
3.
Molina FS, Avgidou K., Kagan KO, Poggi S., Nicolaides KHCystic hygromas, nuchal edema, and nuchal translucency at 11-14 weeks of gestation . Obstet Gynecol. 2006;107:678-683.
4.
Bronshtein M. , Zimmer EZ, Blazer S.A characteristic cluster of fetal sonographic markers that are predictive of fetal Turner syndrome in early pregnancy. Am J Obstet Gynecol. 2003;188: 1016-1020.
5.
Malone FD, Ball RH, Nyberg DA, et al. First-trimester septated cystic hygroma: prevalence, natural history, and pediatric outcome. Obstet Gynecol. 2005;106:288-294.
6.
Chervenak FA , Isaacson G., Blakemore KJ, et al. Fetal cystic hygroma: cause and natural history. N Engl J Med. 1983;309: 822-825.
Van der Putte SCLymphatic malformation in human fetuses: a study of fetuses with Turner's syndrome or status BonnevieUllrich. Virchows Arch A Pathol Anat Histol. 1977;376:233-246.
9.
Chitayat D., Kalousek DK, Bamforth JSLymphatic abnormalities in fetuses with posterior cervical cystic hygroma . Am J Med Genet. 1989;33:352-356.
10.
von Kaisenberg CS, Nicolaides KH, Brand-Saberi B.Lymphatic vessel hypoplasia in fetuses with Turner syndrome. Hum Reprod. 1999;14:823-826.
11.
Vittay P., Bosze P., Gaal M., Laszlo J.Lymph vessel defects in patients with ovarian dysgenesis. Clin Genet. 1980;18:387-391.
12.
Gittenberger-De Groot AC, Van Den Akker NM, Bartelings MM, Webb S., van Vugt JM, Haak MCAbnormal lymphatic development in trisomy 16 mouse embryos precedes nuchal edema. Dev Dyn. 2004;230:378-384.
13.
Bekker MN, Haak MC, Rekoert-Hollander M., Twisk JWR, van Vugt JMG.Increased nuchal translucency and distended jugular lymphatic sacs by first-trimester ultrasound. Ultrasound Obstet Gynecol. 2005 ;25:239-245.
14.
Bekker MN, Van Den Akker NM, Bartelings MM, et al. Nuchal edema and venous-lymphatic phenotype disturbance in human fetuses and mouse embryos with aneuploidy. J Soc Gynecol Investig . 2006;13:209-216.
15.
Wilting J., Aref Y., Huang R., et al. Dual origin of avian lymphatics. Dev Biol. 2006;292:165-173.
16.
Lymboussaki A., Partanen TA, Olofsson B., et al. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors. Am J Pathol. 1998;153:395-403.
17.
Paavonen K. , Mandelin J., Partanen T., et al. Vascular endothelial growth factors C and D and theirVEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium. J Rheumatol. 2002;29:39-45.
18.
Partanen TA , Makinen T., Arola J., Suda T., Weich HA, Alitalo K.Endothelial growth factor receptors in human fetal heart. Circulation. 1999;100:583-586.
19.
Saaristo A. , Veikkola T., Enholm B., et al. Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes. FASEB J. 2002;16:1041-1049.
20.
Soker S., Miao HQ, Nomi M., Takashima S., Klagsbrun M.VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhanceVEGF165-receptor binding. J Cell Biochem. 2002;85:357-368.
21.
le Noble F. , Moyon D., Pardanaud L., et al. Flow regulates arterial-venous differentiation in the chick embryo yolk sac. Development. 2004;131:361-375.
22.
Makinen T., Adams RH, Bailey J.,et al. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev. 2005;19:397-410.
23.
Pandya PP, Snijders RJM, Johnson SP, De Lourdes Brizot M. , Nicolaides KHScreening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation . Br J Obstet Gynaecol. 1995;102:957-962.
24.
Schacht V., Ramirez MI, Hong YK, et al. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 2003 ;22:3546-3556.
25.
Petrova TV, Makinen T., Makela TP, et al. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J . 2002; 21:4593-4599.
26.
Sabin FRThe lymphatic system in human embryos, with a consideration of the morphology of the system as a whole. Am J Anat. 1909;9:43-91.
27.
Wigle JT, Harvey N., Detmar M., et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 2002;21:1505-1513.
28.
Wilting J., Papoutsi M., Christ B., et al.The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues. FASEB J. 2002;16:1271-1273.
29.
Miyabara S., Sugihara H., Maehara N., et al. Significance of cardiovascular malformations in cystic hygroma: a new interpretation of the pathogenesis. Am J Med Genet. 1989;34:489-501.
30.
Gruden G., Thomas S., Burt D., et al. Mechanical stretch induces vascular permeability factor in human mesangial cells: mechanisms of signal transduction. Proc Natl Acad Sci U S A. 1997;94:12112-12116.
31.
Lantieri LA, Martin-Garcia N., Wechsler J., Mitrofanoff M., Raulo Y., Baruch JPVascular endothelial growth factor expression in expanded tissue: a possible mechanism of angiogenesis in tissue expansion. Plast Reconstr Surg. 1998;101:392-398.
32.
Kalousek DK , Seller MJDifferential diagnosis of posterior cervical hygroma in previable fetuses. Am J Med Genet Suppl . 1987;3:83-92.
33.
Larcher F., Murillas R., Bolontrade M., Conti CJ, Jorcano JLVEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Oncogene . 1998;17:303-311.
34.
Flamme I., von Reutern M., Drexler HC, Syed-Ali S., Risau W.Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation. Dev Biol. 1995;171:399-414.
35.
Brandenburg H., Bartelings MM, Wisse LJ, Steegers EA, Gittenberger-De Groot ACIncreased expression of vascular endothelial growth factor in cardiac structures of fetus with hydrops as compared to nonhydropic controls. Fetal Diagn Ther . 2006;21:84-91.
36.
Nagy JA,Vasile E., Feng D., et al.Vascular permeability factor/ vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med . 2002;196:1497-1506.
